Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urinary Bladder Neoplasms × Capecitabine × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 30 Breast Neoplasms 26 Pancreatic Neoplasms 18 Neoplasm Metastasis 16 Stomach Neoplasms 13 Rectal Neoplasms 12 Neoplasms 10 Esophageal Neoplasms 8 Triple Negative Breast Neoplasms 6 Colorectal Cancer Metastatic 6 Colonic Neoplasms 6 Brain Neoplasms 4 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Bile Duct Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Non-Hodgkin 2 Liver Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Adenocarcinoma Of Esophagus 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

pembrolizumab 13 Gemcitabine 13 Cisplatin 10 avelumab 6 Nivolumab 6 Docetaxel 6 enfortumab vedotin 5 atezolizumab 5 sacituzumab govitecan 4 durvalumab 4 Paclitaxel 4 Carboplatin 4 vofatamab 3 tremelimumab 3 Mitomycin 3 Cystectomy 3 vinflunine 2 tisotumab vedotin 2 poly ICLC 2 aldesleukin 2 Radiotherapy 2 Ipilimumab 2 Immunoglobulin G 2 Cystoscopy 2 Clinical Trials, Phase II as Topic 2 BCG Vaccine 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03844256 2022-08-12

CRIMI

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡